Research Focus: Targeting CEACAM5 With Novel Antibody–Drug Conjugates in Nonsquamous Non-Small-Cell Lung Cancer

Gain insight from expert faculty as they discuss the importance of molecular testing in NSCLC, emerging investigational antibody–drug conjugates targeting CEAMCAM5, and the potential role in nonsquamous NSCLC with a text module, downloadable slideset, and expert commentary.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Sanofi.

Sanofi